Lipoteichoic acid synergizes with glycosphingolipids to potently stimulate secretion of interleukin-6 from human blood cells

Clinical and Vaccine Immunology

Volumn 15, Issue 9, 2008, Pages 1309-1315

  Meron Sudai, Shiri ^a   Matityahou, Ariella ^a   Keisari, Yona ^a   Cox, Kathleen H ^b   Hasty, David L ^b,c   Ofek, Itzhak ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL LIPOPEPTIDE PAM3CYSK4; CYTOKINE; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GLOBOSIDE; GLYCOSPHINGOLIPID; HEMOGLOBIN; INTERLEUKIN 6; KERASIN; LACTOSYLCERAMIDE; LIPOPEPTIDE; LIPOTEICHOIC ACID; OLIGOMER; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DOT HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LIPID ANALYSIS; MEMBRANE COMPONENT; MICELLIZATION; MOLECULAR INTERACTION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SUBCRITICAL MICELLE CONCENTRATION;

BLOOD; DRUG SYNERGISM; GLYCOSPHINGOLIPIDS; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MONOCYTES; PEPTIDES; TEICHOIC ACIDS;

EID: 51649088466     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00060-08     Document Type: Article

References (34)

1. Alexander, C., and E. T. Reitschel. 2001. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7:167-202.
2. Alkan, M. L., and E. H. Beachey. 1978. Excretion of lipoteichoic acid by group A streptococci: influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J. Clin. Investig. 61:671-677.
3. Brandenburg, K., and A. Wiese. 2004. Endotoxins: relationships between structure, function, and activity. Curr. Top. Med. Chem. 4:1127-1146.
4. Brandenburg, K., P. Garidel, J. Andrä, G. Jürgens, M. Müller, A. Blume, M. H. J. Koch, and J. Levine. 2003. Cross-linked hemoglobin converts endotoxically inactive pentaacyl endotoxins into a physiologically active conformation. J. Biol. Chem. 278:47660-47669.
5. Brett, P. J., M. N. Burtnick, D. S. Snyder, J. G. Shannon, P. Azadi, and F. C. Gherardini. 2007. Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol. Microbiol. 63:379-390.
6. Caroff, M., D. Karibian, J. M. Cavaillon, and N. Haeffner-Cavaillon. 2002. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect. 4:915-926.
7. Cox, K. H., I. Ofek, and D. L. Hasty. 2007. Enhancement of macrophage stimulation by lipoteichoic acid and the co-stimulant, hemoglobin, is dependent on Toll-like receptors 2 and 4. Infect. Immun. 75:2638-2643.
8. Dawson, G., A. W. Kruski, and A. M. Scanu. 1976. Distribution of glyco-sphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias. J. Lipid Res. 17:125-131.
9. Drobnik, W., G. Liebisch, F. X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz. 2003. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J. Lipid Res. 44:754-761.
10. Galanos, C., and M. A. Freudenberg. 1993. Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187:346-356.
11. Gay, N. J., and M. Gangloff. 2007. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76:141-165.
12. Ginsburg, I. 2002. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. Dis. 2:171-179.
13. Hashimoto, M., M. Furuyashiki, R. Kaseya, Y. Fukada, M. Akimaru, K. Aoyama, T. Okuno, T. Tamura, T. Kirikea, F. Kirikea, N. Eiraku, H. Morioka, Y. Fujimoto, K. Fukase, K. Takashige, Y. Moriya, S. Kusumoto, and Y. Suda. 2007. Evidence of immunostimulating lipoprotein existing in the natural lipoteichoic acid fraction. Infect. Immun. 75:1926-1932.
14. Hasty, D. L., S. Meron-Sudai, K. H. Cox, T. Nagorna, E. Ruiz-Bustos, E. Losi, H. S. Courtney, E. A. Mahrous, R. Lee, and I. Ofek. 2006. Monocyte and macrophage activation by lipoteichoic acid is independent of alanine and is potentiated by hemoglobin. J. Immunol. 176:5567-5576.
15. Ishii, N., and A. Watanabe. 1989. Analysis of autoantibodies to glycolipids on thymocytes in New Zealand Black mice. Immunology 68:215-220.
16. Ito, H., N. Koide, F. Hassan, S. Islam, G. Tumurkhuu, I. Mori, T. Yoshida, S. Kakumu, H. Moriwaki, and T. Yokochi. 2006. Lethal endotoxic shock using a-galactosylceramide sensitization as a new experimental model of septic shock. Lab. Investig. 86:254-261.
17. Keisari, Y. 1996. Human mononuclear phagocytes in tissue culture, p. 153-160. In G. E. Jones (ed.), Methods in molecular medicine: human cell culture protocols. Humana Press Inc., Totowa, NJ.
18. Lotz, S., E. Aga, I. Wilde, G. van Zandbergen, T. Hartung, W. Solbach, and T. Laskay. 2004. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukoc. Biol. 75:467-477.
19. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193:393-397.
20. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, and T. Hartung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195:1635-1640.
21. Schwarz, M., L. Spector, A. Gargir, A Shtevi, M. Gortler, R. T. Altstock, A. A. Dukler, and N. Dotan. 2003. A new kind of carbohydrate array, its use for profiling antiglycan antibodies, and the discovery of a novel human cellulose-binding antibody. Glycobiology 13:749-754.
22. Senn, H. J., M. Orth, E. Fitzke, H. Wieland, and W. Gerok. 1989. Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Eur. J. Biochem. 181:657-662.
23. Small, D. M. 1986. The physical chemistry of lipids from alkanes to phospholipids, p. 285. Plenum Publishing Corp, New York, NY.
24. Sole, R. V., and H. Fellermann. 2005. Lipid world. Molecular dynamics of lipid aggregates. http://complex.upf.es/∼harold/lipid_world/ rndex.html.
25. Su, D., R. I. Roth, and J. Levin. 1999. Hemoglobin infusion augments the tumor necrosis factor response to bacterial endotoxin (lipopolysaccharide) in mice. Crit. Care Med. 27:771-778.
26. Su, D., R. I. Roth, M. Yoshida, and J. Levin. 1997. Hemoglobin increases mortality from bacterial endotoxin. Infect. Immun. 65:1258-1266.
27. Tanford, C. 1980. The hydrophobic effect. Formation of micelles & biological membranes, 2nd ed. Wiley-Interscience, Hoboken, NJ.
28. Teti, G. 1999. Septic shock caused by gram-positive bacteria. Trends Microbiol. 7:100-101.
29. Traub, S., S. von Aulock, T. Hartung, and C. Hermann. 2006. MDP and other muropeptides - direct and synergistic effects on the immune system. J. Endotoxin Res. 12:69-85.
30. Triantafilou, M., M. Manukyan, A. Mackie, S. Morath, T. Hartung, H. Heine, and K. Triantafilou. 2004. Lipoteichoic acid and Toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279:40882-40889.
31. Von Aulock, S., T. Hartung, and C. Hermanm. 2007. Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus." J. Immunol. 178:2610.
32. Wicken, A. J., and K. W. Knox. 1977. Biological properties of lipoteichoic acids, p. 360-365. In D. Schlessinger (ed.), Microbiology. ASM Press, Washington, DC.
33. Wicken, A. J., J. D. Evans, and K. W. Knox. 1986. Critical micelle concentrations of lipoteichoic acids. J. Bacteriol. 166:72-77.
34. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to influence inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69:2045-2053.